The FAA administrator's comments come on the eve of his visit to Boeing facilities outside Seattle. While there, he's scheduled to meet with Boeing executives and be briefed...Airlinesread more
CBS, CNN and other major media companies are starting to pull e-cigarette advertising off their airways, as the death toll from a mysterious vaping-related illness continues...Health and Scienceread more
Investors largely expected the FOMC to cut rates by a quarter point.The Fedread more
Investors bought bank stocks because there's a chance the Federal Reserve's interest rate cut may "put an end to this artificially inverted yield curve," Jim Cramer says.Mad Money with Jim Cramerread more
AT&T is considering selling DirecTV, according to a report in the Wall Street Journal.Technologyread more
The Facebook CEO will talk to policymakers "about future internet regulation," according to a spokesperson.Technologyread more
As the Fed was meeting to consider cutting interest rates, it lost control of the very benchmark rate that it manages.Market Insiderread more
Disney CEO Bob Iger writes in his autobiography that he believes he would have discussed combining Disney with Apple had Steve Jobs lived.Technologyread more
The decision to cut rates followed a monthslong pressure campaign by Trump, who often criticized Chairman Jerome Powell by name as he called for lower interest rates.Politicsread more
Microsoft shares rose 1% after hours as it announced plans to raise its dividend and authorized as much as $40 billion to buy back shares.Technologyread more
The Fed cut interest rates by a quarter point, but it also reaffirmed its rate cut was meant to serve as insurance for the economy.Market Insiderread more
Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales.
Third-quarter earnings before interest, tax, depreciation and amortisation (EBITDA), adjusted for one-off items, came in at 2.2 billion euros ($2.5 billion), the company said on Tuesday, above an average estimate for 2.05 billion in a Reuters poll of analysts.
Bayer's best-selling stroke prevention drug Xarelto contributed to the positive surprise with a better-than-expected 933 million euros in quarterly sales, helped by a wider range of health conditions for which the pill can be prescribed.
Animal Health earnings almost halved to 44 million euros mainly because U.S. pet owners had brought the purchase of Advantage flea, tick and worm control products forward to the first half of the year, it said.
Earnings from the newly acquired Monsanto business played a lesser role because only about 20 percent of full-year EBITDA from that business are typically generated during the second half of the year, due to the seasonality of farming.
Bayer said the number of U.S. plaintiffs seeking damages over claims that Monsanto's Roundup and Ranger Pro herbicides can cause cancer had risen to 9,300, up from 8,700 reported previously.
It confirmed a forecast for adjusted core earnings per share for 2018 to decline to 5.70 to 5.90 euros, from 6.64 euros in 2017.